Simvastatin potenciates PGI2 release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL

This publication has 34 references indexed in Scilit:

• Atheroprotective Effects of High-Density Lipoproteins
  Annual Review of Medicine, 2003
• Prostacyclin synthase gene transfer modulates cyclooxygenase-2-derived prostanoid synthesis and inhibits neointimal formation in rat balloon-injured arteries.
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2002
• Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries
  Circulation, 2001
• High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase
  Nature Medicine, 2001
• Cyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis
  Circulation, 2000
• Cyclooxygenase-1 and -2 isoenzymes
  Published by Elsevier ,1999
• Cyclooxygenase-2 Is Widely Expressed in Atherosclerotic Lesions Affecting Native and Transplanted Human Coronary Arteries and Colocalizes With Inducible Nitric Oxide Synthase and Nitrotyrosine Particularly in Macrophages
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
  Proceedings of the National Academy of Sciences, 1999
• Eicosanoids and atherosclerosis
  Current Opinion in Lipidology, 1993
• Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.
  Journal of Clinical Investigation, 1990